Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bugu Shengsui Decoction for Primary Osteoporosis
NCT05370898Unknown
- Sponsor
- 中国中医科学院望京医院
- Start
- Jul 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Bugu Shengsui Decoction in primary osteoporosis (2 arms), sponsored by 中国中医科学院望京医院. Primary endpoints: Visual Analogue Score of low back at 3 months, Traditional Chinese Medicine syndrome score at 3 months and 5 more. Status: unknown.
02
Drugs
Bugu Shengsui Decoction
03
Conditions
primary osteoporosis
Beyond the preview
Go deeper on NCT05370898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05370898.